LD-2 disclosure · 3rd Quarter - Report
ALLIANCE FOR PHARMACY COMPOUNDING
Client
- Description
- Non-profit association promoting the practice of pharmacy compounding
- Location
- Texas · United States of America
Registrant
- Description
- Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2024 Appropriations HR167, the Patient Access to Urgent Use Compounded Medication Act
LobbyistsJIM TURNER · MICHAEL TOMBERLIN · THERESA REED · TAYLOR SEYL · mr ROBERT DAVID PORE
Covered position (JIM TURNER): Member of Congress 1997-2005
Covered position (MICHAEL TOMBERLIN): Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep., Louie Gohmert
Covered position (mr ROBERT DAVID PORE): Legislative Director, Cong. Jim Turner
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2024 Appropriations HR167, the Patient Access to Urgent Use Compounded Medication Act
LobbyistsJIM TURNER · MICHAEL TOMBERLIN · THERESA REED · TAYLOR SEYL · mr ROBERT DAVID PORE
Covered position (JIM TURNER): Member of Congress 1997-2005
Covered position (MICHAEL TOMBERLIN): Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep. Louie Gohmert
Legislative Director, Cong. Jim Turner